all report title image
  • Published On : May 2022
  • Code : CMI1805
  • Industry : Pharmaceutical
  • Pages : 202
  • Formats :

Lidocaine patch is a transdermal formulation available through hospital, retail, and online pharmacies. It is most commonly prescribed for pain relief. Besides, it is used to treat pain related to nerve diseases, ease long-term pain problems, and to ease pain caused by shingles.

The global lidocaine patches market is estimated to be valued at US$ 1,055.6 million in 2022 and is expected to exhibit a CAGR of 7.8% during the forecast period (2022-2030).

Figure 1. Global Lidocaine Patches Market, in Terms of Value (US$ Million), By Region, 2022

Lidocaine Patches  | Coherent Market Insights

Introduction of generic lidocaine patch products is expected to drive the global lidocaine patches market growth during the forecast period.

Generic lidocaine patch is significantly cheaper, compared to the brand version. Thus, increase in preference for generic lidocaine patch is expected to create opportunities for market players to launch new generic version of lidocaine patch and thereby drive growth of the market. For instance, Amneal Pharmaceuticals, Inc., a fully-integrated pharmaceutical company, announced that it received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for a generic version of Lidocaine Patch, 5%, in August 2020.

CMI table icon

Lidocaine Patches Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 1,055.6 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 7.8% 2030 Value Projection: US$ 1,926.8 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Strength: 5%, 4%, Others (10%, 20%, etc.)
  • By Adhesive Material: Aqueous, Non-aqueous
  • By Application: Post Herpetic Neuralgia (PHN), Pain Indications
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Companies covered:

Endo International plc, Teva Pharmaceutical Industries Ltd, Viatris Inc. (Mylan N.V.), Teikoku Pharma USA, Inc., Hisamitsu Pharmaceuticals Co. Inc., Galen Limited, Sorrento Therapeutics, Inc., Amneal Pharmaceuticals, Inc., Rhodes Pharmaceuticals L.P., 6iPain Healthcare Private Limited, and Sanofi S.A.

Growth Drivers:
  • Introduction of generic products 
  • Technological innovation
Restraints & Challenges:
  • Presence of alternative treatment options   

Figure 2. Global Lidocaine Patches Market Share (%), By Strength, 2022

Lidocaine Patches  | Coherent Market Insights

Technological innovation in lidocaine patch is expected to drive the global market growth over the forecast period

Technological innovation with better adhesion is expected to drive demand for lidocaine patch products. Thus, key players are engaged in investing in research and development to introduce newer lidocaine patch products in the market and this is expected to drive growth of the market. For instance, in February 2018, Sorrento Therapeutics, Inc., a clinical-stage, antibody-centric, biopharmaceutical company, and its majority-owned subsidiary, Scilex Pharmaceuticals Inc., received approval from the U.S. Food and Drug Administration (FDA) for ZTlido (lidocaine topical system) 1.8%. ZTlido is a major advancement in analgesics because of its proprietary adhesion technology demonstrating 12-hour wear with efficient lidocaine delivery, even during exercise.

Global Lidocaine Patches Market – Impact of Coronavirus (COVID-19) Pandemic

COVID-19 has resulted in several challenges in healthcare sector, especially to ensure continuity of treatment during this pandemic period. It has significantly affected healthcare systems and economies within a short timeframe. The pandemic is directly affecting the production and demand, creating disruptions in distribution channels of lidocaine patch, which resulted in decrease in revenue of manufacturer of lidocaine patch. Thus, COVID-19 pandemic has negative impact on global lidocaine patch market growth.

Global Lidocaine Patches Market: Restraints

Anticonvulsants, certain antidepressants, opioid painkillers, and others are the alternative options to treat pain associated with postherpetic neuralgia. For instance, opioids are highly used in the management of various other pain conditions. This is expected to limit the use of lidocaine patch and thereby expected to hinder growth of the market.

Key Players                   

Major players operating in the global lidocaine patches market include Endo International plc, Teva Pharmaceutical Industries Ltd, Viatris Inc. (Mylan N.V.), Teikoku Pharma USA, Inc., Hisamitsu Pharmaceuticals Co. Inc., Galen Limited, Sorrento Therapeutics, Inc., Amneal Pharmaceuticals, Inc., Rhodes Pharmaceuticals L.P., 6iPain Healthcare Private Limited, and Sanofi S.A.

Lidocaine falls under the drug class of local anesthesia. Lidocaine patches are adhesive formulations that are used to help reduce itching and pain from certain skin conditions. Dermalid, Lidoderm, Ztildo are the prescription lidocaine transdermal patches used to relieve the pain of post-herpetic neuralgia. However, Absorbine Jr, Aspercreme, Lidocare, and Salonpas, among others are non-prescription lidocaine patches available to relieve minor pain in shoulders, arms, neck, and legs in adults and children 12 years of age and older.

Market Dynamics

Increase in application of lidocaine patch in pain management is expected to drive growth of the global lidocaine patch market over the forecast period. The lidocaine patch 5% exhibits efficacy to treat pain related to postherpetic neuralgia and is effective for pain related to osteoarthritis, creating an effective topical analgesic option for osteoarthritis. Moreover, increase in orevalence of lower back pain (LBP) is expected to boost growth of the market in the near future. For instance, according to an article published in Elsevier B.V. in January 2022, there were 568.4 million (95 ​% UI 505.0 to 640.6 million) prevalent cases of LBP (Low Back Pain) in 2019, with an age-standardized point prevalence estimate of 6,972.5 (95 ​% UI 6190.5 to 7860.5) per 100,000 population, globally.  Additionally, increasing incidence of herpes zoster and lack of preventive vaccination against shingles are expected to boost demand for lidocaine patches, which is further expected to fuel growth of the global lidocaine patches market during the forecast period. For instance, according to data published by the Centers for Disease Control and Prevention in October 2020, an estimated one million cases of herpes zoster occur annually in the U.S. The incidence for herpes zoster is around 4 cases per 1,000 U.S. population annually.

Key features of the study:

  • This report provides an in-depth analysis of the global lidocaine patches market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global lidocaine patches market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
  • Key companies covered as a part of this study include Endo International plc, Teva Pharmaceutical Industries Ltd, Viatris Inc. (Mylan N.V.), Teikoku Pharma USA, Inc., Hisamitsu Pharmaceuticals Co. Inc., Galen Limited, Sorrento Therapeutics, Inc, Amneal Pharmaceuticals, Inc., Rhodes Pharmaceuticals L.P., 6iPain Healthcare Private Limited, and Sanofi S.A.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global lidocaine patches market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global lidocaine patches market

Detailed Segmentation:

  • Global Lidocaine Patches Market, By Strength:
    • 5%
    • 4%
    • Others (10%, 20%, etc.)
  • Global Lidocaine Patches Market, By Adhesive Material:
    • Aqueous
    • Non-aqueous
  • Global Lidocaine Patches Market, By Application:
    • Post Herpetic Neuralgia (PHN)
    • Pain Indications
  • Global Lidocaine Patches Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Lidocaine Patches Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Endo International plc*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Teva Pharmaceutical Industries Ltd
    • Viatris Inc. (Mylan N.V.)
    • Teikoku Pharma USA, Inc.
    • Hisamitsu Pharmaceuticals Co. Inc.
    • Galen Limited
    • Sorrento Therapeutics, Inc
    • Amneal Pharmaceuticals, Inc.
    • Rhodes Pharmaceuticals L.P.
    • 6iPain Healthcare Private Limited
    • Sanofi S.A.

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global lidocaine patches market is estimated to be valued at US$ 1,055.6 million in 2022 and is expected to exhibit a CAGR of 7.8% between 2022 and 2030.
Technological innovation in lidocaine patch is expected to drive the market growth over the forecast period.
5% segment is holding a major market share in the market.
The major factor hampering growth of the market include presence of alternative treatment option.
Major players operating in the market include Endo International plc, Teva Pharmaceutical Industries Ltd, Viatris Inc. (Mylan N.V.), Teikoku Pharma USA, Inc., Hisamitsu Pharmaceuticals Co. Inc., Galen Limited, Sorrento Therapeutics, Inc., Amneal Pharmaceuticals, Inc., Rhodes Pharmaceuticals L.P., 6iPain Healthcare Private Limited, and Sanofi S.A.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo